COVID-19 vaccination for children with cancer

Rishi S Kotecha^{1

2

3}

Affiliations

¹ Department of Clinical Haematology, Oncology and Bone Marrow Transplantation, Perth Children's Hospital, Perth, Western Australia, Australia.
² Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.
³ Curtin Medical School, Curtin University, Perth, Western Australia, Australia.

Comment

Rishi S Kotecha. Pediatr Blood Cancer. 2022 Feb.

. 2022 Feb;69(2):e29340.

doi: 10.1002/pbc.29340. Epub 2021 Sep 14.

Rishi S Kotecha^{1

2

3}

¹ Department of Clinical Haematology, Oncology and Bone Marrow Transplantation, Perth Children's Hospital, Perth, Western Australia, Australia.
² Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.
³ Curtin Medical School, Curtin University, Perth, Western Australia, Australia.

No abstract available

Comment on

Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study.
Monin L, Laing AG, Muñoz-Ruiz M, McKenzie DR, Del Molino Del Barrio I, Alaguthurai T, Domingo-Vila C, Hayday TS, Graham C, Seow J, Abdul-Jawad S, Kamdar S, Harvey-Jones E, Graham R, Cooper J, Khan M, Vidler J, Kakkassery H, Sinha S, Davis R, Dupont L, Francos Quijorna I, O'Brien-Gore C, Lee PL, Eum J, Conde Poole M, Joseph M, Davies D, Wu Y, Swampillai A, North BV, Montes A, Harries M, Rigg A, Spicer J, Malim MH, Fields P, Patten P, Di Rosa F, Papa S, Tree T, Doores KJ, Hayday AC, Irshad S. Monin L, et al. Lancet Oncol. 2021 Jun;22(6):765-778. doi: 10.1016/S1470-2045(21)00213-8. Epub 2021 Apr 27. Lancet Oncol. 2021. PMID: 33930323 Free PMC article.

1. Frenck RW, Klein NP, Kitchin N, et al. Safety, immunogenicity, and efficacy of the BNT162b2 Covid‐19 vaccine in adolescents. N Engl J Med. 2021;385(3):239‐250. - PMC - PubMed
1. Han B, Song Y, Li C, et al. Safety, tolerability, and immunogenicity of an inactivated SARS‐CoV‐2 vaccine (CoronaVac) in healthy children and adolescents: a double‐blind, randomised, controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021. 10.1016/S1473-3099(21)00319-4 - DOI - PMC - PubMed
1. Jude St Global. Global registry of COVID‐19 in pediatric cancer. Accessed August 25, 2021. https://global.stjude.org/en‐us/global‐covid‐19‐observatory‐and‐resource...
1. Mukkada S, Bhakta N, Chantada GL, et al. Global characteristics and outcomes of SARS‐CoV‐2 infection in children and adolescents with cancer (GRCCC): a cohort study. Lancet Oncol. 2021. 10.1016/S1470-2045(21)00454-X - DOI - PMC - PubMed
1. Kotecha RS. Challenges posed by COVID‐19 to children with cancer. Lancet Oncol. 2020;21(5):e235. - PMC - PubMed